Heterolignans: Stereoselective synthesis of an 11-amino analog of azaelliptitoxin

European Journal of Organic Chemistry

Volumn , Issue 34, 2008, Pages 5687-5691

  Routier, Julie ^a   Calancea, Mihaela ^a   David, Marion ^a   Vallée, Yannick ^a   Denis, Jean Noël ^a  

^a UNIVERSITÉ JOSEPH FOURIER   (France)

Author keywords

amino aldehydes; Azaelliptitoxin; Bioactive heterolignans; Pictet spengler reaction; Stereoselective synthesis

Indexed keywords

EID: 56749149418     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200800880     Document Type: Article

References (54)

1. a) D. A. Whiting, Nat. Prod. Rep. 1990, 7, 349-364;
2. b) M. Gordaliza, M. A. Castro, J. M. Miguel del Corral, A. San Feliciano, Curr. Pharm. Des. 2000, 6, 1811-1839;
3. c) S. Apers, A. Vlietinck, L. Pieters, Phytochem. Rev. 2004, 2, 201-207;
4. d) G. P. Moss, Pure Appl. Chem. 2000, 72, 1493-1523;
5. e) R. S. Ward, Nat. Prod. Rep. 1999, 16, 75-96;
6. f) R. S. Ward, Nat. Prod. Rep. 1995, 12, 183-205;
7. g) R. S. Ward, Phytochem. Rev. 2004, 2, 391-400.
8. a) R. S. Ward, Synthesis 1992, 719-730;
9. b) J. Chang, J. Reiner, J. Xie, Chem. Rev. 2005, 105, 4581-4609;
10. c) R. S. Ward, Phytochem. Rev. 2003, 2, 391-400.
11. a) T. F. Imbert, Biochimie 1998, 80, 207-222;
12. b) Z.-Q. Wang, H. Hu, H.-X. Chen, Y.-C. Cheng, K.-H. Lee, J. Med. Chem. 1992, 35, 871-877;
13. c) Y.-L. Zhang, X. Guo, Y.-C. Cheng, K.-H. Lee, J. Med. Chem. 1994, 37, 446-452;
14. d) J. D. Sellars, P. G. Steel, Eur. J. Org. Chem. 2007, 3815-3828.
15. Azaelliptitoxin is the best well-known heterolignan for its biological activities. The generic name "heterolignan" was first introduced by Medarde et al., see: M. Medarde, R. Peláez-Lamamié de Clairac, F. Tomé, J. L. Lopez, A. San Feliciano, Arch. Pharm. 1995, 328, 403-407.
16. a) F. Leleurtre, J. Madalengoitia, A. Orr, T. J. Cuzy, E. Lehnert, T. Macdonald, Y. Pommier, Cancer Res. 1992, 52, 4478-4483;
17. b) E. Solary, F. Leteurtre, K. D. Paull, D. Scudiero, E. Hamel, Y. Pommier, Biochem. Pharmacol. 1993, 45, 2449-2456;
18. c) J. J. Tepe, J. S. Madalengoitia, K. M. Slunt, K. W. Werbovetz, P. G. Spoors, T. L. Macdonald, J. Med. Chem. 1996, 39, 2188-2196;
19. d) T. A. Miller, P. R. Vachaspati, M. A. Labroli, C. D. Thompson, A. L. Bulman, T. L. Macdonald, Bioorg. Med. Chem. Lett. 1998, 8, 1065-1070;
20. e) B. Eymin, E. Solary, S. Chevillard, L. Dubrez, F. Goldwasser, O. Duchamp, P. Genne, F. Leteurtre, Y. Pommier, Int. J. Cancer 1995, 63, 268-275;
21. f) F. Leleurtre, D. L. Sackett, J. Madalengoitia, G. Kohlhagen, T. Macdonald, E. Hamel, K. D. Paull, Y. Pommier, Biochem. Pharmacol. 1995, 49, 1283-1290;
22. g) J. S. Madalengoitia, J. J. Tepe, K. A. Werbovetz, E. K. Lehnert, T. L. Macdonald, Bioorg. Med. Chem. 1997, 5, 1807-1815.
23. L. F. Liu, Annu. Rev. Biochem. 1989, 58, 351-375.
24. a) S. Katsumura, A. Kondo, Q. Han, Chem. Lett. 1991, 1245-1248;
25. b) S. Katsumura, N. Yamamoto, M. Morita, Q. Han, Tetrahedron: Asymmetry 1994, 5, 161-164.
26. D. B. Dess, J. C. Martin, J. Org. Chem. 1983, 48, 4155-4156.
27. D. More, N. S. Finney, Org. Lett. 2002, 4, 3001-3003.
28. For a recent review, see: U. Ladziata, V. V. Zhdankin, ARKIVOC 2006, 10, 26-58.
29. [7]
30. (+)-(R)-Mosher's acid [(+)-(R)-MTPA] was used as chiral derivating agent.
31. Selected references: a) G. Wang, Anti-Infective Agents Med. Chem. 2008, 7, 32-49 and references cited therein;
32. b) G. Zappia, P. Menendez, G. D. Monache, D. Misiti, L. Nevola, B. Botta, Mini-Rev. Med. Chem. 2007, 7, 389-409;
33. c) J.-F. Li, R. Yang, L. Nie, L.-J. Yang, R. Huang, J. Lin, J. Pept. Res. 2005, 66, 319-323;
34. d) S. Aubry, S. Pellet-Rostaing, M. Lemaire, Eur. J. Org. Chem. 2007, 5212-5225;
35. e) D. A. Evans, Aldrichim. Acta 1982, 15, 23-32;
36. f) D. J. Ager, I. Prakash, D. R. Schaad, Aldrichim. Acta 1997, 30, 3-12;
37. g) D. J. Ager, I. Prakash, D. R. Schaad, Chem. Rev. 1996, 96, 835-875;
38. h) J. L. Charlton, G.-L. Chee, Can. J. Chem. 1997, 75, 1076-1083;
39. i) J. T. Randolph, P. Waid, C. Nichols, D. Sauer, F. Haviv, G. Diaz, G. Bammert, L. M. Besecke, J. A. Segreti, K. M. Mohning, E. N. Bush, C. D. Wegner, J. Greer, J. Med. Chem. 2004, 47, 1085-1097;
40. j) C. Murruzzu, M. Alonso, A. Canales, J. Jimenez-Barbero, A. Riera, Carbohydr. Res. 2007, 342, 1805-1812;
41. k) M. S. M. Pearson, M. Evain, M. Mathé-Allainmat, J. Lebreton, Eur. J. Org. Chem. 2007, 4888-4894;
42. l) M. S. M. Pearson, R. O. Saad, T. Dintinger, H. Amri, M. Mathé-Allainmat, J. Lebreton, Bioorg. Med. Chem. Lett. 2006, 16, 3262-3267.
43. a) J.-N. Denis, H. Mauger, Y. Vallée, Tetrahedron Lett. 1997, 38, 8515-8518;
44. b) H. Chalaye-Mauger, J.-N. Denis, M.-T. Averbuch-Pouchot, Y. Vallée, Tetrahedron 2000, 56, 791-804;
45. c) M. David, J.-N. Denis, C. Philouze, A. Durif, Y. Vallée, C. R. Chim. 2004, 7, 41-44.
46. In this reaction, the use of electron-donating alkyl protecting groups, such as the methyl group to give the dimethylamino moiety, led to the degradation of the reaction mixture probably by initial formation of the corresponding azafulvenium salt by removal of dimethylamine.
47. a) D. H. R. Barton, J. Camara, P. Dalko, S. D. Géro, B. Quiclet-Sire, P. Stütz, J. Org. Chem. 1989, 54, 3764-3766;
48. b) D. K. Pyun, C. H. Lee, H.-J. Ha, C. S. Park, J.-W. Chang, W. K. Lee, Org. Lett. 2001, 3, 4197-4199.
49. Masked carbonyl groups are known to give cleaner reactions in several cases than the corresponding carbonyl groups, see: C. C. Silveira, A. S. Vieira, T. S. Kaufman, Tetrahedron Lett. 2006, 47, 7545-7549 and references cited therein.
50. a) E. D. Cox, J. M. Cook, Chem. Rev. 1995, 95, 1797-1842;
51. b) E. L. Larghi, M. Amongero, A. B. J. Bracca, T. S. Kaufman, ARKIVOC 2005, 12, 98-153;
52. c) B. E. Maryanoff, H.-C. Zhang, J. H. Cohen, I. J. Turchi, C. A. Maryanoff, Chem. Rev. 2004, 104, 1431-1628.
53. K. Tomioka, Y. Kubota, K. Koga, Tetrahedron 1993, 49, 1891-1900, and references therein.
54. [18]